Seramount Ranks Gilead Sciences Among Its Leading Inclusion Index Company
Gilead Sciences has been recognized as a Leading Inclusion Index Company by Seramount, highlighting its commitment to fostering connections, creating opportunities for underrepresented groups, and cultivating a sense of belonging. This prestigious acknowledgment places Gilead among 42 organizations receiving this distinction in 2024.
Gilead Sciences is a research-based biopharmaceutical company that focuses on discovering, developing, and commercializing innovative medicines for unmet medical needs. The company aims to transform and simplify care for people with life-threatening illnesses globally. With operations in over 35 countries and headquarters in Foster City, California, Gilead continues to make strides in both medical innovation and workplace inclusion.
Gilead Sciences è stata riconosciuta come una Leading Inclusion Index Company da Seramount, evidenziando il suo impegno a favorire connessioni, creare opportunità per gruppi sotto rappresentati e coltivare un senso di appartenenza. Questo prestigioso riconoscimento colloca Gilead tra le 42 organizzazioni che ricevono questa distinzione nel 2024.
Gilead Sciences è una società biopharmaceutical di ricerca che si concentra sulla scoperta, sviluppo e commercializzazione di medicinali innovativi per bisogni medici insoddisfatti. L'azienda mira a trasformare e semplificare le cure per le persone affette da malattie potenzialmente mortali a livello globale. Con operazioni in oltre 35 paesi e sede a Foster City, California, Gilead continua a compiere progressi sia nell'innovazione medica che nell'inclusione sul posto di lavoro.
Gilead Sciences ha sido reconocida como una Leading Inclusion Index Company por Seramount, destacando su compromiso de fomentar conexiones, crear oportunidades para grupos subrepresentados y cultivar un sentido de pertenencia. Este prestigioso reconocimiento posiciona a Gilead entre las 42 organizaciones que reciben esta distinción en 2024.
Gilead Sciences es una empresa biofarmacéutica basada en la investigación que se enfoca en descubrir, desarrollar y comercializar medicamentos innovadores para necesidades médicas insatisfechas. La empresa tiene como objetivo transformar y simplificar la atención para personas con enfermedades potencialmente mortales a nivel mundial. Con operaciones en más de 35 países y sede en Foster City, California, Gilead continúa avanzando tanto en innovación médica como en inclusión laboral.
길리어드 사이언스는 세람아우트에 의해 우수 포용 지수 회사로 인정받아 연결을 촉진하고, 대표성이 부족한 그룹을 위한 기회를 창출하며 소속감을 고양하는 데 대한 헌신을 강조합니다. 이 권위 있는 인정을 통해 2024년에 이 상을 받는 42개 조직 중 하나로 길리어드가 자리잡게 되었습니다.
길리어드 사이언스는 연구 기반의 생물 제약 회사로, 충족되지 않은 의료 필요에 대한 혁신적인 의약품을 발견, 개발 및 상용화하는 데 주력하고 있습니다. 이 회사는 생명을 위협하는 질병에 걸린 사람들을 위해 전 세계적으로 치료를 변화시키고 단순화하는 것을 목표로 하고 있습니다. 35개국 이상에서 운영되고 있으며, 캘리포니아주 포스터 시티에 본사를 둔 길리어드는 의료 혁신과 직장 내 포용성 모두에서 계속해서 발전하고 있습니다.
Gilead Sciences a été reconnue comme une Leading Inclusion Index Company par Seramount, mettant en évidence son engagement à favoriser les connexions, à créer des opportunités pour les groupes sous-représentés et à cultiver un sentiment d'appartenance. Cette prestigieuse reconnaissance place Gilead parmi les 42 organisations à recevoir cette distinction en 2024.
Gilead Sciences est une entreprise biopharmaceutique axée sur la recherche qui se consacre à la découverte, au développement et à la commercialisation de médicaments innovants pour des besoins médicaux non satisfaits. L'entreprise vise à transformer et simplifier les soins pour les personnes souffrant de maladies potentiellement mortelles à l'échelle mondiale. Avec des opérations dans plus de 35 pays et son siège à Foster City, Californie, Gilead continue de faire des progrès tant en matière d'innovation médicale que d'inclusion sur le lieu de travail.
Gilead Sciences wurde von Seramount als Leading Inclusion Index Company ausgezeichnet, was das Engagement des Unternehmens zur Förderung von Verbindungen, zur Schaffung von Chancen für unterrepräsentierte Gruppen und zur Kultivierung eines Zugehörigkeitsgefühls hervorhebt. Diese angesehene Anerkennung platziert Gilead unter den 42 Organisationen, die 2024 diese Auszeichnung erhalten.
Gilead Sciences ist ein forschungsbasiertes biopharmazeutisches Unternehmen, das sich auf die Entdeckung, Entwicklung und Vermarktung innovativer Arzneimittel für unbefriedigte medizinische Bedürfnisse konzentriert. Das Unternehmen hat zum Ziel, die Versorgung von Menschen mit lebensbedrohlichen Erkrankungen weltweit zu transformieren und zu vereinfachen. Mit Niederlassungen in über 35 Ländern und Hauptsitz in Foster City, Kalifornien, macht Gilead weiterhin Fortschritte sowohl in der medizinischen Innovation als auch in der Arbeitsplatzintegration.
- None.
- None.
NORTHAMPTON, MA / ACCESSWIRE / September 10, 2024 / This year, we're among 42 organizations being recognized by Seramount as a Leading Inclusion Index Company. The recognition highlights the connections we foster, the opportunities we create for underrepresented groups and the sense of belonging we cultivate.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
FAQ
What recognition did Gilead Sciences (GILD) receive from Seramount in 2024?
How many companies were recognized as Leading Inclusion Index Companies alongside Gilead Sciences (GILD)?
What is the main focus of Gilead Sciences (GILD) as a biopharmaceutical company?
Where is Gilead Sciences (GILD) headquartered?
In how many countries does Gilead Sciences (GILD) have operations?
